None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - The study participant is able to understand the nature, significance and scope of the clinical study. - An informed consent form personally signed and dated by the study participant or his/her legal representative before any study-specific measure is performed. - Children, adolescents, and young adults =13 and =25 years of age.
Exclusion criteria
Exclusion criteria: - Hypersensitivity to the test product or one of the components of the test products (e.g. ultrasound gel). - Medical or psychological circumstances that may jeopardize the proper conduct of the clinical study. - Injuries that could influence a statement regarding the bone age according to Greulich and Pyle.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary efficacy endpoint is the clinical success rate of the system in determining the age of majority in subjects of different ethnicities between 13 and 25 years of age. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary efficacy point is the system's clinical success rate in determining the age of majority for girls and boys (or young women and men) between the ages of 13 and 25 with additional differentiation of ethnicities or origins. | — |
Countries
Germany
Contacts
Klinik für Allgemeine Pädiatrie und Neonatologie